Entwodiksyon ak aplikasyon CAS:146087-19-6|hydroxysaflor jòn A
Hydroxysaflor jòn A gen efè antioksidan ak terapetik sou maladi kè kardyovaskulèr, tronboz serebral, hyperlipidemia, ak timè.
Pake ak transpò CAS:146087-19-6|hydroxysaflor jòn A
Pake: 20mg, 100mg;
Transpò: pa courrier / pa lè / pa lanmè.
Atik ki gen rapò ak CAS:146087-19-6|hydroxysaflor jòn A
Efè neropwotektif hydroxysaflor jòn A: etid in vivo ak vitro
H Zhu, Z Wang, C Ma, J Tian, F Fu, C Li, D Guo… - Planta …, 2003 - thieme-connect.com
Efè hydroxysaflor jòn A sou tansyon ak fonksyon kadyak
PH Nie, L Zhang, WH Zhang, WF Rong… - Journal of …, 2012 - Elsevier
Baj popilè: cas:146087-19-6|hydroxysaflor jòn a, Lachin cas:146087-19-6|hydroxysaflor jòn yon manifakti yo, faktori









![Nimewo CAS 83683-82-3|4-Nitro-1H-pyrrolo[2,3-b]piridin](/uploads/202340266/small/cas-no-83683-82-3-4-nitro-1h-pyrrolo-2-3-ba3037d22-f5ee-44c5-b4f6-98d379f7421f.jpg?size=195x0)
![N-[(S)-(+)-1-(Etoksikarbonil)-3-phenylpropyl]-L-alanine CAS 82717-96-2](/uploads/202340266/small/n-s-1-ethoxycarbonyl-3-phenylpropyl-l-alanine8b7bcfb1-8e10-48cb-97df-6b3363215cde.png?size=195x0)